Vanguard Group Inc Alx Oncology Holdings Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,887,002 shares of ALXO stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,887,002

Previous 1,884,573 0.13%

Holding current value

$2 Million

Previous $3.43 Million 8.11%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$1.21 - $1.87 $2,939 - $4,542	2,429 Added 0.13%	1,887,002 $3.15 Million
Q3 2024 Nov 13, 2024	BUY	$1.81 - $8.13 $284,758 - $1.28 Million	157,325 Added 9.11%	1,884,573 $3.43 Million
Q2 2024 Aug 13, 2024	BUY	$5.84 - $17.56 $938,978 - $2.82 Million	160,784 Added 10.26%	1,727,248 $10.4 Million
Q1 2024 May 10, 2024	BUY	$10.95 - $16.79 $701,402 - $1.08 Million	64,055 Added 4.26%	1,566,464 $17.5 Million
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $2.38 Million - $7.6 Million	494,173 Added 49.01%	1,502,409 $22.4 Million
Q3 2023 Nov 14, 2023	BUY	$4.19 - $7.35 $6,905 - $12,112	1,648 Added 0.16%	1,008,236 $4.84 Million
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $126,515 - $276,771	-28,951 Reduced 2.8%	1,006,588 $7.56 Million
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $1.76 Million - $4.56 Million	-389,759 Reduced 27.35%	1,035,539 $4.68 Million
Q4 2022 Feb 10, 2023	BUY	$9.51 - $12.95 $135,888 - $185,042	14,289 Added 1.01%	1,425,298 $16.1 Million
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $710,018 - $1.31 Million	86,272 Added 6.51%	1,411,009 $13.5 Million
Q2 2022 Aug 12, 2022	SELL	$5.89 - $19.46 $2.07 Million - $6.83 Million	-350,919 Reduced 20.94%	1,324,737 $10.7 Million
Q1 2022 May 13, 2022	SELL	$13.65 - $22.06 $441,959 - $714,258	-32,378 Reduced 1.9%	1,675,656 $28.3 Million
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $612,593 - $2.12 Million	28,506 Added 1.7%	1,708,034 $36.7 Million
Q3 2021 Nov 12, 2021	BUY	$52.51 - $80.91 $6.82 Million - $10.5 Million	129,810 Added 8.38%	1,679,528 $124 Million
Q2 2021 Aug 13, 2021	BUY	$52.2 - $75.23 $80.9 Million - $117 Million	1,549,718 New	1,549,718 $84.7 Million

Others Institutions Holding ALXO

# of Institutions

Shares Held

39.5M

Call Options Held

213K

Put Options Held

44.8K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $43.2M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Alx Oncology Holdings Inc Transaction History